Topic archive

u.s. department of health and human services

10 stories

10/21/2026

Matt Zorn on ibogaine, psychedelics policy at HHS

Matt Zorn discusses his transition from legal adversary to HHS official.

10/9/2026

Gabon aims to secure benefits from rising ibogaine demand

10/8/2026

Federal funds may replace private investment in Texas ibogaine research

10/8/2026

FDA outlines early-stage ibogaine trial design, inviting public feedback.

9/17/2026

Psychedelic therapies gain momentum as potential treatments for combat-related trauma.

9/14/2026

Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.

9/10/2026

Filament Health begins stability program for IBEX011 amid rising ibogaine demand.

9/10/2026

IBEX011 stability program aims to meet growing demand for standardized ibogaine.

8/26/2026

The move promotes open science and could influence future psychedelic research.

7/15/2026

New agreement includes ibogaine research for opioid use disorder.